0001144204-13-046088.txt : 20130815 0001144204-13-046088.hdr.sgml : 20130815 20130814180802 ACCESSION NUMBER: 0001144204-13-046088 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130815 DATE AS OF CHANGE: 20130814 EFFECTIVENESS DATE: 20130815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Knoll Capital Management, LP CENTRAL INDEX KEY: 0001325083 IRS NUMBER: 133476926 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11424 FILM NUMBER: 131039611 BUSINESS ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-808-7474 MAIL ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001325083 XXXXXXXX 06-30-2013 06-30-2013 false Knoll Capital Management, LP

5 East 44th Street 12th floor New York NY 10017

13F HOLDINGS REPORT 028-11424 N Fred Knoll 646-590-3960 /s/ Fred Knoll New York NY 08-14-2013 0 11 146208 INFORMATION TABLE 2 infotable.xml Newlink Genetics Corp Com 651511107 935 47437 SH SOLE 47437 0 0 Medivation, Inc. Com 58501N101 123202 2504101 SH SOLE 2504101 0 0 Sequenom Inc. Com New 817337405 3907 928100 SH SOLE 928100 0 0 Keryx Biopharmaceuticals Inc. Com 492515101 747 100000 SH SOLE 100000 0 0 Achillion Pharmaceuticals Inc. Com 00448Q201 450 55000 SH SOLE 55000 0 0 Echo Therapeutics Inc. Com New 27876L206 111 444445 SH SOLE 444445 0 0 Ampio Pharmaceuticals Inc. Com 03209T109 7550 1308455 SH SOLE 1308455 0 0 Vivus Inc. Call 928551900 1430 5000 SH Call SOLE 5000 0 0 Genworth Financial Inc. Com Cl A 37247D106 3651 320000 SH SOLE 320000 0 0 Celgene Corp Com 151020104 204 27925 SH SOLE 27925 0 0 Alcobra Ltd SHS M2239P109 4021 587000 SH SOLE 587000 0 0